Total laparoscopic radical hysterectomy with para-aortic and pelvic lymphadenectomy for stage IIA squamous cell carcinoma of the cervix: A case report

Chilaris GH1,2, Tsoumpis T1, Alarkof E3, Karkotis K4, Daveta A5

1Department of Gynecology and Laparoscopic Surgery, Iaso hospital
2Center for Special Minimally Invasive Surgery, Stanford University Medical Center, Palo Alto, USA
3Department of Urology, Iaso hospital
4Department of Gastrenterology, Iaso hospital
5Department of Anesthesiology, Iaso hospital

Correspondence: Chilaris GE, Center for Special Minimally Invasive Surgery, Stanford University Medical Center, 900 Welch Road, Palo Alto, CA 94304, USA


Abstract

The role of laparoscopy in the management of abdominopelvic malignancies is constantly evolving. Recebt data from clinical trials demonstrate that laparoscopic surgical staging has equal efficacy (lymph node counts, disease free survival) compared to traditional open cases and can be safely performed in selected patients. We report a case of laparoscopic radical hysterectomy and lymphadenectomy performed in a 44 years old G1P1 female with squamous cell carcinoma of the cervix, stage IIA. Nineteen nodes were retrieved, two of which were positive for metastasis. She suffered a left lower extremity venous thrombosis for which she received standard treatment with parenteric heparin and eventually oral coumadin. The patient required only one analgesic suppository for postoperative pain control and remained afebrile throughout her hospitalization. She received adjuvant chemoradiation due to risk factors and is now under a standard surveillance schedule. The present case supports the fact that laparoscopic surgical staging as an alternative method of modern surgical oncology can be performed in properly selected patients. To our knowledge, a total laparoscopic radical hysterectomy with bilateral para-aortic and pelvic lymphadenectomy has not been previously described in our country.

Keywords: cervical cancer, laparoscopy, hysterectomy, ovarian cancer, uterine cancer

p. 279-291